CDT logo

Conduit Pharmaceuticals (CDT) Cash From Operations

Annual CFO

-$7.72 M
-$5.46 M-240.91%

December 31, 2023


Summary


Performance

CDT Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCDTcash flowmetrics:

Quarterly CFO

-$2.00 M
-$486.00 K-32.12%

September 29, 2024


Summary


Performance

CDT Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCDTcash flowmetrics:

TTM CFO

-$10.67 M
-$1.48 M-16.04%

September 29, 2024


Summary


Performance

CDT TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCDTcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

CDT Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-240.9%-281.5%-265.2%
3 y3 years-259.1%-281.5%-265.2%
5 y5 years-259.1%-281.5%-265.2%

CDT Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-259.1%at low-367.1%+58.4%-1254.3%at low
5 y5-year-259.1%at low-367.1%+58.4%-1254.3%at low
alltimeall time-259.1%at low-367.1%+58.4%-1254.3%at low

Conduit Pharmaceuticals Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2.00 M(+32.1%)
-$10.67 M(+16.0%)
Jun 2024
-
-$1.51 M(-35.8%)
-$9.20 M(+13.4%)
Mar 2024
-
-$2.36 M(-50.9%)
-$8.11 M(+5.0%)
Dec 2023
-$7.72 M
-$4.80 M(+816.6%)
-$7.72 M(+164.4%)
Sep 2023
-
-$524.00 K(+22.4%)
-$2.92 M(+21.9%)
DateAnnualQuarterlyTTM
Jun 2023
-
-$428.00 K(-78.3%)
-$2.40 M(+21.7%)
Mar 2023
-
-$1.97 M(+150.0%)
-$1.97 M(+150.0%)
Dec 2022
-$2.27 M(+5.3%)
-
-
Mar 2022
-
-$788.00 K
-$788.00 K
Dec 2021
-$2.15 M
-
-

FAQ

  • What is Conduit Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for Conduit Pharmaceuticals?
  • What is Conduit Pharmaceuticals annual CFO year-on-year change?
  • What is Conduit Pharmaceuticals quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Conduit Pharmaceuticals?
  • What is Conduit Pharmaceuticals quarterly CFO year-on-year change?
  • What is Conduit Pharmaceuticals TTM cash flow from operations?
  • What is the all time high TTM CFO for Conduit Pharmaceuticals?
  • What is Conduit Pharmaceuticals TTM CFO year-on-year change?

What is Conduit Pharmaceuticals annual cash flow from operations?

The current annual CFO of CDT is -$7.72 M

What is the all time high annual CFO for Conduit Pharmaceuticals?

Conduit Pharmaceuticals all-time high annual cash flow from operations is -$2.15 M

What is Conduit Pharmaceuticals annual CFO year-on-year change?

Over the past year, CDT annual cash flow from operations has changed by -$5.46 M (-240.91%)

What is Conduit Pharmaceuticals quarterly cash flow from operations?

The current quarterly CFO of CDT is -$2.00 M

What is the all time high quarterly CFO for Conduit Pharmaceuticals?

Conduit Pharmaceuticals all-time high quarterly cash flow from operations is -$428.00 K

What is Conduit Pharmaceuticals quarterly CFO year-on-year change?

Over the past year, CDT quarterly cash flow from operations has changed by -$1.48 M (-281.49%)

What is Conduit Pharmaceuticals TTM cash flow from operations?

The current TTM CFO of CDT is -$10.67 M

What is the all time high TTM CFO for Conduit Pharmaceuticals?

Conduit Pharmaceuticals all-time high TTM cash flow from operations is -$788.00 K

What is Conduit Pharmaceuticals TTM CFO year-on-year change?

Over the past year, CDT TTM cash flow from operations has changed by -$7.75 M (-265.23%)